RecruitingNot ApplicableNCT05152264

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

High Frequency, High Intensity Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain - a Randomized Controlled Trial


Sponsor

Göteborg University

Enrollment

40 participants

Start Date

Nov 12, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Conventional analgesic treatment and a medical device called Transcutaneous electrical nerve stimulation (TENS) for people with endometriosis-related pain. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscutaneous electrical nerve stimulation (TENS)

Treatment with transcutaneous electrical nerve stimulation (TENS) during 16 weeks.

OTHERConventional analgesic treatment

Conventional analgesic treatment. Conventional analgesic treatment may include no pharmacological treatment if the patient does not use any analgesics.


Locations(1)

Pain Centre, Department of Anaesthesiology and Intensive Care Medicine Östra, Sahlgrenska University Hospital, Region Västra Götaland

Gothenburg, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05152264


Related Trials